Review of the cardiac long-term effects of therapy for Hodgkin lymphoma

Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines

(2010) D. Bovelli et al.   ANNALS OF ONCOLOGY

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease

(2010) S. Myrehaug et al.   BLOOD

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation

(2010) S. L. Galper et al.   BLOOD

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

(2010) S. M. Castellino et al.   BLOOD

Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

(2010) Lesley A Smith et al.   BMC CANCER

Coronary artery disease mortality in patients treated for hodgkin's disease

(2010) Jean-François Boivin et al.   CANCER

ACR Appropriateness Criteria®: Follow-Up of Hodgkin's Lymphoma

(2010) Andrea Ng et al.   CURRENT PROBLEMS IN CANCER

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques

(2010) Laura Cella et al.   Radiation Oncology

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

(2009) Lawrence H. Young et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

(2009) Andreas Engert et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244

(2009) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

(2009) Massimo Federico et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of Coronary Artery Disease by Computed Tomography Angiography in Patients Treated for Childhood Hodgkin's Lymphoma

(2009) Serhan Küpeli et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardioprotective Effect of Dexrazoxane in Patients with Breast Cancer Treated with Anthracyclines in Adjuvant Setting

(2008) Franco Testore et al.   American Journal of Cardiovascular Drugs

Coronary Artery Disease After Radiation Therapy for Hodgkin's Lymphoma: Coronary CT Angiography Findings and Calcium Scores in Nine Asymptomatic Patients

(2008) Jürgen Rademaker et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

(2008) C. Kobe et al.   BLOOD

Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapy

(2008) Sten Myrehaug et al.   LEUKEMIA & LYMPHOMA

Involved-Node Radiotherapy in Early-Stage Hodgkin’s Lymphoma

(2008) Hans Theodor Eich et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: Dose constraints to virtual volumes or to organs at risk?

(2007) Mithra Ghalibafian et al.   RADIOTHERAPY AND ONCOLOGY